Key points
- Only purchase from pharmacies registered with the GPhC (General Pharmaceutical Council) and regulated by the CQC
- The MHRA has issued multiple warnings about counterfeit Ozempic and semaglutide products in the UK
- Legitimate online services always require a clinical consultation before dispensing a prescription-only medicine
- Counterfeit pens have been found containing insulin, which can cause life-threatening hypoglycaemia
- Ozempic is licensed for diabetes; Wegovy is the approved product for weight management in the UK
The rise of online weight loss prescriptions
Demand for semaglutide and other GLP-1 medications in the United Kingdom has surged since 2023. NHS supply constraints, long waiting lists for Tier 3 weight management services, and widespread media coverage have driven millions of people to seek these medications privately, often through online prescribing platforms.
While many online services are entirely legitimate, operating under the same regulatory framework as high-street pharmacies, the rapid growth of demand has also attracted unscrupulous operators and outright criminal enterprises selling counterfeit products. Understanding how to distinguish safe from dangerous sources is essential to protecting your health.
The UK regulatory framework
In England, Scotland and Wales, online pharmacies and prescribing services are regulated by two principal bodies.
General Pharmaceutical Council (GPhC)
The GPhC regulates pharmacists and pharmacy premises across Great Britain. Any pharmacy dispensing prescription medications online must hold a valid GPhC registration. The GPhC maintains a public register that you can search at pharmacyregulation.org.
Registered online pharmacies are required to display the GPhC internet pharmacy logo — a distinctive green cross with a unique registration number. Clicking this logo should take you directly to the GPhC register entry for that pharmacy.
Care Quality Commission (CQC)
The CQC regulates healthcare services in England, including online prescribing services that employ doctors or prescribers. If an online weight loss clinic provides consultations and issues prescriptions, it should be registered with the CQC. You can verify registration at cqc.org.uk.
CQC registration means the service is inspected for safety, effectiveness, caring, responsiveness and leadership — the same standards applied to NHS services and high-street GP practices.
MHRA (Medicines and Healthcare products Regulatory Agency)
The MHRA authorises which medications can be sold in the UK and monitors drug safety. Since 2024, the MHRA has issued multiple public alerts about counterfeit semaglutide products, including fake Ozempic pens seized at UK borders and found on unregulated websites.
How to verify an online pharmacy
Safety checklist: before you buy
- Check for the GPhC internet pharmacy logo on the website
- Click the logo and confirm it links to the genuine GPhC register
- Verify the GPhC registration number at pharmacyregulation.org
- Check CQC registration for the prescribing service at cqc.org.uk
- Confirm a clinical consultation is required before prescribing
- Check for a named superintendent pharmacist and UK contact details
- Verify a UK postal address is listed (not just a PO box)
- Ensure the medication is dispensed from a UK-based pharmacy
Red flags: when to walk away
Warning signs of an unsafe source
- No GPhC registration logo or a logo that does not link to the register
- No clinical consultation or health questionnaire required
- Prices significantly below the standard UK market rate (£200–£300/month)
- Medication shipped from outside the UK
- No named pharmacist or prescriber on the website
- Payment only by cryptocurrency, wire transfer or untraceable methods
- Social media sellers or marketplace listings (eBay, Facebook, Telegram)
- Claims of “generic Ozempic” (no generic semaglutide injection is approved in the UK)
- No verifiable UK physical address
- Aggressive marketing with unrealistic weight loss promises
The counterfeit threat
Counterfeit GLP-1 medications represent a serious and growing public health risk in the United Kingdom. The MHRA, working with Border Force, has seized multiple consignments of fake semaglutide products entering the country since 2024.
What has been found in counterfeit products
- No active ingredient: Some seized pens contained saline or other inert substances, rendering them ineffective
- Wrong active ingredient: Particularly alarming, some counterfeits have contained insulin. Injecting insulin when you are not diabetic can cause severe hypoglycaemia (dangerously low blood sugar), which can lead to seizures, loss of consciousness and death
- Incorrect dosage: Products with variable or incorrect concentrations of semaglutide can cause unpredictable side effects or inadequate treatment
- Contamination: Non-sterile manufacturing conditions can introduce bacterial or chemical contaminants
- Improper storage: Semaglutide requires cold chain storage (2–8°C before first use). Products shipped without refrigeration may have degraded, reducing efficacy and safety
MHRA alert: If you have purchased semaglutide from an unverified source and experience unexpected symptoms (particularly dizziness, confusion, sweating, tremor or feeling faint), seek immediate medical attention and report the product to the MHRA Yellow Card scheme. These symptoms may indicate hypoglycaemia from a contaminated product.
Ozempic vs Wegovy: understanding the difference
A key point of confusion is the difference between Ozempic and Wegovy. Both contain semaglutide manufactured by Novo Nordisk, but they are licensed for different indications.
| Feature | Ozempic | Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| UK licence | Type 2 diabetes | Weight management + CV risk |
| Maximum dose | 1 mg weekly | 2.4 mg weekly |
| NICE approved for weight loss | No (off-label use only) | Yes |
| Typical private cost | £150–£250/month | £200–£300/month |
Many patients seeking weight loss are prescribed Ozempic off-label because Wegovy has experienced intermittent supply shortages. While off-label prescribing is legal and common in UK medical practice, it does mean the prescriber is taking individual clinical responsibility for the decision. A legitimate online service should explain this distinction to you.
What a legitimate online consultation looks like
A proper online prescribing service for GLP-1 medications should include the following steps.
- Detailed health questionnaire: Covering your medical history, current medications, allergies, BMI, previous weight management attempts and contraindications
- Clinical review by a prescriber: A GMC-registered doctor, or an appropriately qualified independent prescriber, reviews your information and may ask follow-up questions
- Eligibility assessment: Checking that your BMI and clinical profile meet prescribing criteria
- Informed consent: Clear explanation of the medication, potential side effects, dosing schedule and what to expect
- Ongoing monitoring: Legitimate services offer follow-up consultations, dose adjustments and access to clinical support
- Dispensing by a GPhC-registered pharmacy: The medication itself is dispensed by a separately regulated pharmacy
Good practice indicator: The best online prescribing services will decline to prescribe if your clinical profile is unsuitable, refer you to your GP for further assessment, or suggest alternative approaches such as specialist weight loss clinics if appropriate.
Legitimate online providers in the UK
Several established, CQC-registered and GPhC-compliant online services operate in the UK prescribing GLP-1 medications for weight management. Without endorsing specific providers, the following categories of service are generally legitimate:
- NHS-affiliated digital services: Some NHS Tier 3 weight management services now offer remote consultations and GLP-1 prescribing
- Established online pharmacies: Well-known UK pharmacy chains with online prescribing arms (e.g. Boots Online Doctor, LloydsPharmacy Online Doctor)
- Specialist weight management platforms: CQC-registered services that focus specifically on obesity medicine, staffed by clinicians with relevant expertise
- Private GP telehealth services: CQC-registered remote GP services that include weight management among their offerings
What to do if you suspect a counterfeit product
- Stop using it immediately — do not inject any remaining doses
- Seek medical attention if you have any symptoms of concern
- Report to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk)
- Keep the product (including packaging) for potential investigation
- Report the seller to Action Fraud (actionfraud.police.uk) if purchased from an unregulated source
Cold chain and storage: a hidden risk
Semaglutide pens must be stored at 2–8°C (refrigerated) before first use. Once in use, a pen can be kept at room temperature (below 30°C) for up to 56 days. This cold chain requirement is one reason why purchasing from unregulated or overseas sources is risky — medications shipped without proper refrigeration may have degraded.
A legitimate UK pharmacy will dispatch your medication in temperature-controlled packaging with appropriate cold packs. If your medication arrives warm, without insulation, or with broken packaging, contact the pharmacy immediately and do not use it.
Learn more about proper injection technique in our guide on how to inject Ozempic.